INFORMED.
LIVE

Ind-Swift Laboratories Ltd.

BSE: INDSWFTLAB532305ISIN INE915B01019
  • Healthcare
  • Pharmaceuticals

Share price

₹373.10-4.70 (-1.24%)
as of 18 Sep 2026
Ind-Swift Laboratories Ltd. share price, 18 Sep 2025 to 18 Sep 2026: ₹105.26 to ₹373.10 (+254.5%). Low ₹88.19, high ₹388.20. Volume shown below the price.
52W high
₹403.00
52W low
₹87.00
Off 52W high
-7.42%
1M return
+15.74%
3M return
+99.25%
6M return
+163.21%
1Y return
+254.46%
20D avg volume
61,233
50 DMA
₹297.74
200 DMA
₹175.27

Key ratios Consolidated

Market cap
₹3,245 Cr
Current price
₹373.10
52W high / low
₹403.00 / ₹87.00
Face value
₹10.00
P/E
56.60
P/B
EPS (TTM)
₹6.59
Book value / share
ROE
ROCE
3.60%
Operating margin
Net margin
Debt / equity
0.01
Net debt
₹-411.94 Cr
Interest cover
36.04
Dividend yield
Dividend / share (TTM)
Payout
Cash conversion cycle
114.2 days

Financials

MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q4 FY24
Income statement
191.45169.79150.85152.64152.73138.24
7.652.2227.5817.8614.584.46
166.31154.90156.19160.16156.96128.11
81.7674.2066.0366.1065.4016.25
13.507.269.8511.898.6633.91
39.5637.2231.9536.2732.5331.32
0.71-2.430.672.011.15-26.76
7.588.128.846.986.687.44
40.1350.5244.4837.2543.5158.40
32.8017.1122.2510.3410.3514.58
-0.24-5.15-5.850.000.00215.88
32.5611.9616.3910.3410.35230.46
7.99-3.154.002.301.718.19
24.6815.119.547.998.77222.27
2.841.811.171.001.2832.96
Key metrics
40.8517.6525.9019.3318.18211.14
21.30%10.40%17.20%12.70%11.90%152.70%
12.90%8.90%6.30%5.20%5.70%160.80%
0.70%0.90%16.70%
25.40%22.80%
181.40%-93.20%
MetricTTMFY26FY25FY24
Income statement
664.73641.29561.71
55.3146.9781.38
637.56628.21608.50
288.09271.74224.20
42.5037.6670.80
145.00137.98117.52
0.961.402.92
31.5230.6124.48
172.38175.77175.63
82.5060.0534.59
-11.24-11.01223.20
71.2549.05257.80
11.147.737.27
57.3241.42250.48
6.824.9537.25
Key metrics
103.7381.06285.20
15.60%12.60%50.80%
8.62%6.50%44.60%
3.60%21.40%
14.20%
-83.50%
-150.90-89.88
-1.53-0.10
0.010.03
-411.94-387.42
114.2109.5
Balance sheet
1,6731,438
976.75865.35
429.85428.04
198.55164.52
147.93114.18
158.42105.01
275.14260.07
145.86110.23
254.70220.58
17.9140.62
5.6114.91
12.3025.71
1,3841,173
Cash flow
-63.18-25.47
-72.68-109.62
141.8169.20
87.7264.41
MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q4 FY24
Income statement
186.08172.70149.48150.44147.99144.75
7.632.2127.5817.8614.584.41
161.05158.04153.59157.24152.75138.89
81.7378.2466.1465.9164.4531.77
13.277.269.8511.898.6633.91
38.9537.2031.3935.7332.0030.79
0.71-2.440.672.011.15-26.76
7.588.088.846.986.687.44
38.5950.3342.5635.2841.6657.51
32.6616.8723.4711.069.8310.27
-0.24-5.15-5.850.000.00215.88
32.4311.7217.6111.069.83226.15
7.98-3.224.002.301.718.06
24.4414.9410.748.768.12218.09
2.811.791.321.101.1832.34
Key metrics
40.7217.3627.1220.0517.66206.83
21.90%10.10%18.10%13.30%11.90%142.90%
13.10%8.70%7.20%5.80%5.50%150.70%
0.70%1.00%16.50%
25.70%19.30%
201.00%-93.10%
MetricTTMFY26FY25FY24
Income statement
658.70635.89549.65
55.2846.9681.27
629.92621.62589.98
292.02274.74224.56
42.2737.6670.80
143.27136.33115.33
0.951.402.92
31.4830.5724.48
166.76169.83162.25
84.0661.2240.94
-11.24-11.01223.20
72.8250.22264.14
11.067.668.06
58.8842.56256.09
7.025.0938.08
Key metrics
105.2582.19291.54
15.98%12.90%53.00%
8.94%6.70%46.60%
3.70%22.10%
15.70%
-83.40%
-127.91-103.56
-0.94-0.15
0.010.03
-397.27-375.85
107.8104.2
Balance sheet
1,6541,422
874.91793.73
414.99413.01
188.77160.23
142.98107.25
86.1659.64
275.14258.84
144.01110.46
251.55216.35
17.7237.16
5.6114.62
12.1122.54
1,3711,164
Cash flow
-40.19-39.15
-100.16-109.67
145.2674.22
87.7264.41

Compounded growth

Standalone

Sales CAGR 3Y
Sales CAGR 5Y
Sales CAGR 10Y
Profit CAGR 3Y
Profit CAGR 5Y
Profit CAGR 10Y
Sales YoY (TTM)
Profit YoY (TTM)

Consolidated

Sales CAGR 3Y
Sales CAGR 5Y
Sales CAGR 10Y
Profit CAGR 3Y
Profit CAGR 5Y
Profit CAGR 10Y
Sales YoY (TTM)
Profit YoY (TTM)

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding
42.93%
HolderTypeHoldingPreviousChange
ESSIX BIOSCIENCES LIMITEDPromoter37.81%
ZEAL GLOBAL OPPORTUNITIES FUNDPublic4.62%
NOVA GLOBAL OPPORTUNITIES FUND PCC - TOUCHSTONEPublic2.96%
PANCHKULA FINVEST PRIVATE LIMITEDPublic2.41%
ASHOKKUMAR CHANDAKPublic2.21%
ZAKI ABBAS NASSERPublic2.11%
PRANAV JONEJAPublic1.44%
RAMESHKUMAR JAVERCHAND JAINPublic1.38%
SHARWAN SINGH GULERIAPublic1.24%
NAVRATTAN MUNJALPromoter1.16%
ARK GLOBAL EMERGING COMPANIES, LPPublic1.13%
RISHAV MEHTAPromoter1.10%
NISARG AJAYKUMAR VAKHARIAPublic1.04%
S. R. MEHTAPromoter0.62%
HIMANSHU JAINPromoter0.55%

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

Board meetings

  • Board Meeting - Financial Results